0001567619-23-000965.txt : 20230117 0001567619-23-000965.hdr.sgml : 20230117 20230117215708 ACCESSION NUMBER: 0001567619-23-000965 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230113 FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mueller Brian CENTRAL INDEX KEY: 0001514980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 23532832 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2023-01-13 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001514980 Mueller Brian 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2023-01-13 4 M 0 2500 63.10 A 30246 D Common Stock 2023-01-13 4 S 0 2500 114.50 D 27746 D Stock Option (Right to buy Common Stock) 63.10 2023-01-13 4 M 0 2500 0 D 2014-12-04 2024-06-03 Common Stock 2500 5000 D Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2023-01-17